Bencyclane
Names
IUPAC name
3-[(1-benzylcycloheptyl)oxy]-N,N -dimethylpropan-1-amine
Identifiers
ChEMBL
ChemSpider
ECHA InfoCard
100.016.861
UNII
InChI=1S/C19H31NO/c1-20(2)15-10-16-21-19(13-8-3-4-9-14-19)17-18-11-6-5-7-12-18/h5-7,11-12H,3-4,8-10,13-17H2,1-2H3
Y Key: FYJJXENSONZJRG-UHFFFAOYSA-N
Y InChI=1/C19H31NO/c1-20(2)15-10-16-21-19(13-8-3-4-9-14-19)17-18-11-6-5-7-12-18/h5-7,11-12H,3-4,8-10,13-17H2,1-2H3
Key: FYJJXENSONZJRG-UHFFFAOYAM
O(CCCN(C)C)C1(CCCCCC1)Cc2ccccc2
Properties
C 19 H 31 N O
Molar mass
289.45554
Pharmacology
C04AX11 (WHO )
Except where otherwise noted, data are given for materials in their
standard state (at 25 °C [77 °F], 100 kPa).
Infobox references
Bencyclane is an antispasmodic , vasodilator , and platelet aggregation inhibitor .[ 1]
Synthesis
Synthesis:[ 2] [ 3] Patents:[ 4] [ 5]
Grignard addition of benzylmagnesiumbromide to suberone would give 1-benzylcycloheptanol [4006-73-9] (1' ). Williamson ether synthesis with 3-dimethylaminopropylchloride [109-54-6] (2 ) completed the synthesis of bencyclane (3 ).
See also
References
^ J. Elks, ed. (2014). The Dictionary of Drugs: Chemical Data, Structures and Bibliographies . Springer.
^ Pallos, L.; Budai, Z.; Zólyomi, G. (1972). "Basic ethers of 1-substituted cycloalkanols. 1". Arzneimittel-Forschung . 22 (9): 1502– 1505. PMID 4678613 .
^ Pallos, L.; Budai, Z.; Zólyomi, G. (1972). "Basic ethers of 1-substituted cycloalkanols. 2". Arzneimittel-Forschung . 22 (9): 1505– 1509. PMID 4678614 .
^ Anon., ES 376120 (1972-04-01 to Gallardo Antonio SA).
^ Spaeter Genannt Werden Wird, DE 2455051A1 (1975 to Andreu S A Lab).
Calcium
VDCCs Tooltip Voltage-dependent calcium channels
Blockers
R-type-selective: SNX-482
Activators
Potassium
VGKCs Tooltip Voltage-gated potassium channels
Blockers
KCNQ (Kv 7)-specific: Linopirdine
XE-991
Spooky toxin (SsTx)
Activators
IRKs Tooltip Inwardly rectifying potassium channel
Blockers Activators
GIRK Tooltip G protein-coupled inwardly rectifying potassium channel -specific: ML-297 (VU0456810)
KCa Tooltip Calcium-activated potassium channel
K2Ps Tooltip Tandem pore domain potassium channel
Sodium
VGSCs Tooltip Voltage-gated sodium channels
Blockers
Analgesics: AZD-3161
DSP-2230
Funapide
GDC-0276
NKTR-171
PF-04531083
PF-05089771
Ralfinamide
Raxatrigine
RG7893 (GDC-0287)
Suzetrigine
Activators
ENaC Tooltip Epithelial sodium channel
ASICs Tooltip Acid-sensing ion channel
Chloride
CaCCs Tooltip Calcium-activated chloride channel
CFTR Tooltip Cystic fibrosis transmembrane conductance regulator
Unsorted
Others
TRPs Tooltip Transient receptor potential channels LGICs Tooltip Ligand gated ion channels
See also: Receptor/signaling modulators • Transient receptor potential channel modulators